Related Experiment Video
Updated: Feb 28, 2026

06:05
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
Published on: July 14, 2023
1.7K
Tissue-engineered hypertrophic chondrocyte grafts enhanced long bone repair
Jonathan Bernhard1, James Ferguson2, Bernhard Rieder3
1Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
Biomaterials
|June 17, 2017
Summary
Tissue-engineered bone grafts using hypertrophic chondrocytes, derived from human adipose stem cells (ASC), show promise for repairing critical-size long bone defects. These grafts promote endochondral ossification, leading to enhanced bone regeneration and defect bridging.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Large bone fractures often result in non-unions, exceeding the natural healing capacity.
- Current bone tissue engineering primarily focuses on intramembranous ossification, not the endochondral ossification typical of severe injuries.
- Hypertrophic chondrocytes, crucial for endochondral ossification, have not been extensively studied for long bone defect repair.
Purpose of the Study:
- To investigate the efficacy of tissue-engineered bone grafts using hypertrophic chondrocytes derived from human adipose stem cells (ASC) for critical-size long bone defect repair.
- To compare endochondral ossification-based grafts with traditional osteoblast-based grafts and acellular scaffolds.
- To evaluate the bone regeneration capacity and mechanisms of ASC-derived hypertrophic chondrocytes in vivo.
Main Methods:
- Human adipose stem cells (ASC) were differentiated into hypertrophic chondrocytes.
- These cells were seeded into decellularized bone scaffolds to create tissue-engineered grafts.
- Grafts were implanted into critical-size femoral defects in athymic rats and compared to acellular scaffolds and ASC-derived osteoblast grafts over 12 weeks.
Main Results:
- Hypertrophic chondrocyte grafts successfully recapitulated endochondral ossification, confirmed by gene and protein expression.
- Enhanced bone deposition, extensive bone remodeling, bone marrow formation, and M2 macrophage infiltration were observed in hypertrophic chondrocyte grafts.
- Hypertrophic chondrocyte grafts bridged 7/8 defects, significantly outperforming osteoblast grafts (1/8) and acellular scaffolds (3/8).
Conclusions:
- Tissue-engineered grafts using ASC-derived hypertrophic chondrocytes effectively promote long bone repair via endochondral ossification.
- This approach offers a superior strategy for treating critical-size bone defects compared to current methods.
- The findings support the potential of hypertrophic chondrocytes in osteogenic scaffolds for clinical translation in bone regeneration.

